Next Article in Journal
Updates in Laboratory Identification of Invasive Fungal Infection in Neonates
Previous Article in Journal
Improved Chrysin Production by a Combination of Fermentation Factors and Elicitation from Chaetomium globosum
 
 
Review
Peer-Review Record

Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery

Microorganisms 2023, 11(4), 1000; https://doi.org/10.3390/microorganisms11041000
by Suaidah Ramli 1, Yuan Seng Wu 2,3,*, Kalaivani Batumalaie 4, Rhanye Mac Guad 5, Ker Woon Choy 6, Ashok Kumar 7, Subash C. B. Gopinath 8,9, Md. Moklesur Rahman Sarker 10,11, Vetriselvan Subramaniyan 12,13, Mahendran Sekar 14, Neeraj Kumar Fuloria 15,16, Shivkanya Fuloria 17, Suresh V. Chinni 18,19 and Gobinath Ramachawolran 20,*
Reviewer 1:
Reviewer 2:
Reviewer 3: Anonymous
Microorganisms 2023, 11(4), 1000; https://doi.org/10.3390/microorganisms11041000
Submission received: 14 March 2023 / Revised: 2 April 2023 / Accepted: 7 April 2023 / Published: 12 April 2023
(This article belongs to the Section Virology)

Round 1

Reviewer 1 Report

 

A Prisma flow-diagram need to use for description how to select the studies, articles included in the review, according to:

Page, MJ; McKenzie, JE; Bossuyt, PM; Boutron, I.; Hoffmann, TC; Mulrow, CD; Shamseer, L.; Tetzlaff, JM; Akl, EA; Brennan, SE; Chou, R.; Glanville, J.; Grimshaw, JM; Hróbjartsson, A.;  Lalu, MM; Li, T.; Loder, EW; Mayo-Wilson, E.; McDonald, S.; McGuinness, LA; Stewart, LA; Thomas, J.; Tricco, AC; Welch, VA; Whiting, P.; Moher, D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Journal of Clinical Epidemiology 2021, 134, 178-189.

Page, MJ; McKenzie, JE; Bossuyt, PM; Boutron, I.; Hoffmann, TC; Mulrow, CD; Shamseer, L.; Tetzlaff, JM; Moher, D. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. Journal of Clinical Epidemiology 2021, 134, 103-112.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

The review is well-structured and interesting. It is complete and informative. The major subject is the information about Withania somnifera as a promising phytochemical against COVID problems. What I miss in the review is the lack of information about dynamic molecular studies and in vivo investigations. I would recommend including of some more information on these points, if available.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 3 Report

This manuscript reviews the Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery. The topic is extremely large for this manuscript. The authors should make extensive improvements in order to develop properly their manuscript. Also, not being a new topic, the way of presentation and a suitable amount of data will increase the value of this manuscript. For so many authors it will be a short homework to make all the improvements. Therefore, I recommend specific and major improvements, before any consideration regarding the possible publication, at the level of literature search, editing, and structure, which are listed below:

 

 

Shape suggestions

Please check the Ethics in publication as your paper has 14!!! Authors for a paper with less than 15.5 real pages, in the MDPI format, which occupies 2/3 of a page.

Letters on the Figures should be of similar size with those on the main text. Now, they are very small, almost unreadable.

Figure 4 is blurred, please add a best quality one.

 

 

Content suggestions

Introduction. As the title is about Withania somnifera, a consistent paragraph must be added about its general presentation (not a short sentence (91-92). The ancient use of plants in traditional medicine must be emphasized (thousands of years ago) - I suggest as reference Bungau, S.G.; Popa, V.-C. Between religion and science: some aspects: concerning illness and healing in antiquity, Transylv. Rev., 2015, 26(3), 3-19. (https://www.researchgate.net/publication/286442576_Between_Religion_and_Science_Some_Aspects_Concerning_Illness_and_Healing_in_Antiquity), as to support the statement. Also, you must integrating the plant, detailing its multiple actions https://doi.org/10.3390/biomedicines8120571 , having role in dermatological diseases https://doi.org/10.3390/molecules26092407 , anticancer action https://doi.org/10.1007/s11356-020-09028-0 , etc. Check the above references and proceed consequently

L94-100. As being a Review, the aim of your research should emphasize the novelty it brings to the field, reason for choosing this topicrelevance of the topic. What is actually stated in this paragraph “provide detailed insights for a better understanding…”, “discusses the possible associated…”, “highlights the in silico molecular docking evaluation…” was already, provided, discussed highlighted in the published original papers from where you have inspired. Please reshape.

It must be added a 2nd section of Methodology for literature search/selection or a similar title. It would therefore be advisable to present the methodology for selecting bibliographic resources (databases used and the reason for choosing those data basis, types of documents, filtering results, inclusion/exclusion criteria for manuscripts: language, key words, duplicates, etc.). Moreover, have you searched (graphically) the impact of the topic on the general literature? You would have found out that there are thousands of articles/reviews in the field, much better developed. 

In this new 2nd section, also add a Figure related to the Literature impact on the Withania somnifera/ SARS-CoV-2relationship and related research areas and paper types identified in medical databases/WoS using the most suitable Boolean search operators.

Detail better the virtual screening of substances used in the treatment of SARS-CoV-2 infection https://doi.org/10.1016/j.biopha.2022.113432

Add a new subsection/section where present the efficiency of antiviral treatment in COVID‑19 https://doi.org/10.3892/etm.2021.10080 , the actual drug treatment https://doi.org/10.1016/j.scitotenv.2021.152072https://doi.org/10.1007/s11356-021-17824-5  https://doi.org/10.1016/j.biopha.2022.112700  etc., versus plant based compounds https://doi.org/10.3390/biomedicines9091266 available for SARS-CoV-2. A table would be relevat, having the last column references (Refs.). I am sure that the authors will find the best way in providing it.

Chapter 5 is too poor.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 3 Report

The authors responded to my requests.

Back to TopTop